Lifestyle Medicine and Endometriosis in Viet Nam: Chronic Pelvic Pain, Lifestyle Support, and Timely Diagnosis

Lifestyle Medicine and Endometriosis in Viet Nam: Chronic Pelvic Pain, Lifestyle Support, and Timely Diagnosis

Primary category: Evidence & Clinical Practice

Secondary category: Lifestyle Medicine in Viet Nam

Article type: VLMA Perspective

Last reviewed: October 30, 2026

A university student experiences severe menstrual pain almost every month. On some days, the pain is so intense that she misses classes or struggles with ordinary activities. She has been told that painful periods are common and may improve as she gets older. Hoping to manage the symptoms, she tries pain medication, changes her diet, and begins exercising more regularly.

Eventually, she seeks medical care. An ultrasound does not reveal an obvious abnormality, and she leaves the appointment reassured that everything appears normal. Yet the pain continues, interfering with her studies, sleep, and daily life.

This illustrates one of the difficulties in recognizing endometriosis. Significant symptoms may persist long before the condition is adequately considered. A normal ultrasound does not necessarily exclude endometriosis, and the severity of pain may not correspond closely to the extent of visible disease.

Lifestyle-related interventions can provide useful support. Appropriate nutrition, physical activity, sleep management, and psychological care may improve general health and help selected patients manage aspects of chronic pain. However, evidence for their specific effects on endometriosis remains limited. These approaches should complement appropriate clinical care rather than become reasons to delay diagnosis or established treatment.

For healthcare professionals in Viet Nam, the priority is to recognize symptoms that warrant further assessment, reduce avoidable diagnostic delays, and provide care that reflects the person's pain, daily functioning, reproductive goals, and circumstances.

The Ministry of Health's updated endometriosis guideline, issued in February 2026, provides an important national reference. Together with international recommendations and research published during 2026, it offers an opportunity to examine how evidence-based Lifestyle Medicine can support gynecologic care without overstating what lifestyle interventions can achieve.

Endometriosis Is More Than Painful Menstruation

Endometriosis is a chronic, estrogen-dependent inflammatory condition characterized by the presence of endometrial-like tissue outside the uterus.

The disease may involve superficial lesions on the pelvic peritoneum, ovarian endometriomas, or deep endometriosis affecting structures within or beyond the pelvis. In some cases, lesions involve the bowel, bladder, ureters, abdominal wall, or other anatomical sites.

Inflammation, adhesions, changes in nerve signaling, and other mechanisms can contribute to pain and functional limitations. However, the relationship between the anatomical extent of disease and the severity of symptoms is complex.

The World Health Organization estimates that endometriosis affects approximately 10% of women of reproductive age worldwide, corresponding to around 190 million people. This is a global estimate and should not be interpreted as a nationally measured prevalence for Viet Nam.

Symptoms may include severe menstrual pain, chronic pelvic pain, pain during sexual intercourse, painful bowel movements, urinary symptoms, fatigue, and difficulty becoming pregnant. Some people experience symptoms primarily during menstruation, while others have pain throughout the month. Endometriosis can also occur without prominent pain and may first be investigated during an infertility assessment.

These different presentations help explain why the condition can be overlooked when attention focuses only on menstrual cramps.

Adenomyosis also deserves consideration because it can produce overlapping symptoms. It involves endometrial-like glands and stroma within the muscular wall of the uterus and may coexist with endometriosis.

Viet Nam's 2026 Ministry of Health guideline includes adenomyosis within its broader clinical classification of endometriosis-related conditions. However, adenomyosis and endometriosis have distinct anatomical characteristics and are commonly considered separately in international clinical literature. Their coexistence should not mean that they are treated as identical conditions.

The severity of pain does not consistently correspond to the amount of disease visible on imaging or during surgery. Someone with relatively limited lesions may experience substantial disability, while another person with extensive disease reports fewer symptoms.

Clinical assessment therefore needs to consider the person's experience, functional limitations, and treatment goals alongside anatomical findings.

Severe Menstrual Pain Should Not Be Automatically Dismissed

Menstrual discomfort is common, but pain that repeatedly disrupts school, work, sleep, or everyday activities deserves medical attention.

A young person who misses classes almost every month because of menstrual pain should not simply be told that the symptoms are normal or that she needs to tolerate them. Similarly, someone who frequently requires pain medication, experiences progressively worsening symptoms, or develops pain associated with bowel movements or urination may need further evaluation.

On February 20, 2026, the American College of Obstetricians and Gynecologists announced new clinical guidance on endometriosis diagnosis. Clinical Practice Guideline No. 11 was published in the March 2026 issue of Obstetrics & Gynecology.

The guideline focuses on the clinical, imaging, and surgical evaluation of adolescents and adults of reproductive age with symptoms suggesting endometriosis. It aims to improve diagnostic care and reduce delays in recognizing the condition.

The Vietnamese Ministry of Health's updated guideline, issued on February 11, 2026, also addresses endometriosis in adolescents and young women and emphasizes the importance of early identification.

These developments matter because symptoms often begin during adolescence, when severe menstrual pain may be attributed to normal menstrual development. Repeated reassurance without reassessment can contribute to prolonged symptoms and unnecessary disruption of everyday life.

However, early recognition does not mean that every adolescent with painful periods has endometriosis. Primary dysmenorrhea remains common, and other causes of pelvic pain must also be considered.

A useful clinical approach is to evaluate the severity, pattern, persistence, and functional consequences of symptoms, provide appropriate initial treatment, and reassess when the response is inadequate.

The objective is not to label every painful period as a chronic disease. It is to ensure that persistent or disabling symptoms receive a meaningful clinical response.

Chronic Pelvic Pain Requires a Broader Assessment

Endometriosis is an important cause of chronic pelvic pain, but it is not the only one.

Gastrointestinal, urinary, gynecologic, musculoskeletal, and neurological conditions can produce overlapping symptoms. Irritable bowel syndrome, bladder pain syndrome, pelvic floor muscle dysfunction, and adenomyosis may coexist with endometriosis or contribute independently to pain.

A careful clinical history should explore whether symptoms follow the menstrual cycle, whether bowel movements or urination provoke pain, and whether sexual activity, movement, or other activities influence symptoms.

The assessment may also consider abnormal bleeding, previous surgery, the possibility of pregnancy, medication use, and relevant medical history.

Pelvic examination can provide useful information when clinically appropriate, but it should be conducted with informed consent and sensitivity to the person's age, preferences, symptoms, and circumstances.

A normal pelvic examination does not exclude endometriosis.

Healthcare professionals should also avoid attributing every new episode of pelvic pain to an existing chronic diagnosis.

Sudden severe pelvic pain, particularly when accompanied by possible pregnancy, fainting, significant bleeding, fever, or marked clinical deterioration, may indicate an urgent condition such as ectopic pregnancy, ovarian torsion, or pelvic infection.

These presentations require prompt medical evaluation.

A person with established endometriosis can still develop another acute medical condition. Good long-term care therefore requires recognizing both the chronic disease and the need to reassess new or concerning symptoms.

Diagnosis Does Not Always Require Surgery

Historically, diagnostic laparoscopy played a central role in confirming endometriosis.

Although laparoscopy remains important in selected circumstances, contemporary clinical guidance recognizes that assessment and treatment can begin without surgery in every patient.

On February 11, 2026, the Vietnamese Ministry of Health issued Decision No. 422/QĐ-BYT, promulgating the updated Guidelines for Diagnosis and Treatment of Endometriosis.

The decision took effect on the date of issuance, applies to medical examination and treatment facilities nationwide, and replaced Decision No. 5306/QĐ-BYT dated November 7, 2019.

The updated Vietnamese guideline emphasizes clinical history, examination, and appropriate imaging. It states that laparoscopy is no longer mandatory in every case to establish a diagnosis of endometriosis.

The American College of Obstetricians and Gynecologists' 2026 diagnostic guideline similarly emphasizes timely clinical evaluation and the appropriate use of imaging and surgical assessment.

A presumptive clinical diagnosis based on symptoms, medical history, and relevant examination findings may support empirical treatment while further assessment continues.

This approach can reduce unnecessary delays and invasive procedures, particularly when the clinical presentation supports a reasonable initial treatment strategy.

However, a presumptive diagnosis should not be confused with definitive confirmation of every lesion.

Improvement after hormonal treatment or pain medication may support a management decision, but it does not prove that endometriosis is the only cause of symptoms.

Clinical reassessment remains important when pain persists, worsens, or responds differently from what was expected.

Laparoscopy may still be considered when imaging is negative but clinical suspicion remains substantial, when empirical treatment is unsuccessful or inappropriate, or when surgery is indicated for other clinical reasons.

The important change is that patients do not necessarily need to undergo an invasive procedure before receiving appropriate care.

A Normal Ultrasound Does Not Exclude Endometriosis

Ultrasound is an important investigation in suspected endometriosis because it can identify ovarian endometriomas, some forms of deep endometriosis, and other pelvic abnormalities.

Viet Nam's 2026 guideline identifies transvaginal ultrasound as a primary imaging approach for appropriate patients with suspected pelvic endometriosis.

Other imaging approaches may be considered when transvaginal ultrasound is unsuitable, declined, or clinically inappropriate. The choice should reflect clinical needs, age, circumstances, preferences, and informed consent.

The National Institute for Health and Care Excellence updated its diagnostic recommendations for endometriosis in November 2024. The guidance recommends appropriate ultrasound assessment while emphasizing that normal findings do not exclude the condition.

This limitation is particularly important for superficial peritoneal endometriosis, which may not be visible on routine imaging.

Specialist ultrasound or magnetic resonance imaging may be useful when deep endometriosis is suspected, particularly if bowel, bladder, ureteral, or other complex involvement needs assessment.

However, additional imaging should address a specific clinical question rather than become a routine requirement for every patient.

The expertise of the professional performing and interpreting the examination also influences its diagnostic value.

Viet Nam's 2026 guideline advises against using serum CA-125 as a diagnostic test for endometriosis. The marker can be elevated in several other gynecologic and nongynecologic conditions and lacks sufficient specificity.

A normal CA-125 result also does not exclude the disease.

The practical lesson is to interpret investigations in the context of symptoms and clinical findings. A normal ultrasound should not automatically end the evaluation when clinical suspicion remains substantial, while further testing should be selected according to its potential value in treatment decisions.

Treatment Must Reflect Pain, Disease Characteristics, and Reproductive Goals

Endometriosis is a chronic condition that may require treatment over many years.

The objectives can include reducing pain, improving daily functioning, managing complications, supporting fertility goals, and reducing the likelihood of recurrent symptoms.

The most appropriate approach depends on the person's age, clinical presentation, disease characteristics, previous treatment, associated conditions, preferences, and reproductive plans.

Viet Nam's 2026 guideline emphasizes individualized management, optimization of medical treatment, and avoidance of unnecessary repeated surgery.

Pain medication, including nonsteroidal anti-inflammatory drugs when indicated, may help manage symptoms. However, these medicines have contraindications and potential adverse effects, including gastrointestinal bleeding, kidney injury, and cardiovascular complications in susceptible individuals.

Hormonal therapy is an established component of pain management for many patients who are not currently attempting to conceive.

Options may include combined hormonal contraceptives, progestin-based treatments, and other endocrine therapies.

Gonadotropin-releasing hormone agonists or antagonists may be considered in selected circumstances, with attention to adverse effects, treatment duration, and the potential need for add-back hormonal therapy.

These treatments differ in effectiveness, tolerability, contraindications, and implications for reproduction.

Surgery may be appropriate for selected patients, including those with persistent symptoms despite suitable treatment, complex deep endometriosis, or complications involving other organs.

However, surgery does not guarantee permanent resolution of pain or prevention of recurrence.

Decisions should consider expected benefits, possible complications, treatment history, fertility goals, and the person's preferences.

Lifestyle-related support may help address associated health and functional concerns, but it should not delay necessary medical or surgical management.

Fertility Requires a Different Treatment Conversation

Endometriosis can affect fertility, but not everyone with the condition experiences infertility.

The severity of pain does not reliably predict the likelihood of becoming pregnant, and extensive anatomical disease does not always produce the same reproductive consequences in every person.

For someone who wishes to conceive, treatment decisions may differ substantially from those for a person seeking long-term suppression of pelvic pain.

Many hormonal therapies used to manage endometriosis symptoms are incompatible with attempts to conceive while treatment is being used. Ovarian suppression is also not an established means of improving spontaneous pregnancy rates in endometriosis-associated infertility.

The European Society of Human Reproduction and Embryology recommends against using ovarian suppression solely to improve fertility in women with endometriosis-associated infertility.

The National Institute for Health and Care Excellence similarly advises against hormonal treatment for the purpose of improving spontaneous pregnancy rates in people actively trying to conceive.

This does not mean hormonal treatment is inappropriate for everyone who may want children in the future. It means that treatment goals and timing need to be discussed clearly.

Surgical decisions require particular consideration of reproductive consequences.

For someone with an ovarian endometrioma, surgery may reduce pain or address a specific anatomical concern, but it can also affect healthy ovarian tissue and reduce ovarian reserve.

Viet Nam's 2026 guideline recognizes these potential consequences, particularly when ovarian surgery is repeated.

The European Society of Human Reproduction and Embryology recommends against routinely performing surgery for ovarian endometriomas before assisted reproductive technology solely to improve live-birth rates, because a clear benefit has not been demonstrated and surgery may negatively affect ovarian reserve.

Surgery may still be appropriate for pain, suspicious findings, difficulty accessing follicles, or other individualized clinical indications.

A person experiencing infertility may therefore benefit from timely reproductive specialist assessment rather than prolonged experimentation with unproven diets or supplements.

There is insufficient evidence that a particular lifestyle program, elimination diet, or nutritional supplement reliably improves pregnancy or live-birth rates specifically through treatment of endometriosis.

The appropriate role of lifestyle support is to contribute to general and reproductive health without delaying indicated fertility assessment or treatment.

What Does Current Evidence Say About Diet?

Diet is one of the most frequently discussed lifestyle interventions for endometriosis.

Patients may encounter recommendations to avoid gluten, dairy products, caffeine, red meat, sugar, or entire categories of processed foods. Some are encouraged to follow an anti-inflammatory diet or purchase products described as hormone-balancing supplements.

These recommendations are often supported by biological explanations involving inflammation, estrogen metabolism, or the gut microbiome.

However, biological plausibility does not establish that an intervention improves clinical outcomes.

The European Society of Human Reproduction and Embryology's 2022 guideline concluded that available evidence was insufficient to recommend a specific nonmedical intervention, including nutritional approaches, as an established treatment for endometriosis-related pain or quality-of-life outcomes.

Evidence has continued to develop since then.

A systematic review published in Revista Cuidarte in 2026 examined 13 studies, including seven dietary studies and six exercise studies. Some reported improvements in symptoms and quality of life, but the authors identified substantial limitations involving small samples, heterogeneous interventions, and inconsistent study designs.

A separate scoping review published in the American Journal of Lifestyle Medicine in February 2026 identified 21 studies examining lifestyle-related interventions for pelvic pain in endometriosis or adenomyosis.

Although several interventions showed potential benefits, the studies differed considerably in methodology, sample size, intervention type, and follow-up. The review also identified important gaps concerning sleep, social connection, and other lifestyle domains.

These findings suggest that lifestyle interventions deserve further investigation. They do not establish a particular dietary pattern as a proven treatment for endometriosis.

For many people, a balanced eating pattern supporting nutritional adequacy and general health is more appropriate than broad restrictions without a clear clinical indication.

Dietary counseling should have an identifiable purpose, such as supporting adequate nutrition, managing a coexisting condition, or determining whether a particular adjustment helps an individual symptom.

Improving dietary quality should not be presented as evidence that endometriotic lesions have disappeared or that recurrence has been prevented.

A 2026 Randomized Trial Provides Encouraging but Limited Evidence

A randomized controlled trial published online in August 2026 in the European Journal of Obstetrics & Gynecology and Reproductive Biology provides useful new evidence.

The study enrolled 140 adults aged 18–45 years who continued to experience symptomatic endometriosis despite hormonal treatment.

Participants were randomly assigned either to receive additional coaching focused on a Mediterranean-style diet and physical activity or to continue the comparison care approach without additional structured lifestyle coaching.

The intervention group received counseling approximately every four months during the 12-month study.

At follow-up, the intervention group experienced greater improvements in non-menstrual pelvic pain and pain during defecation than the control group.

The mean reduction in non-menstrual pelvic pain was 1.60 points in the intervention group compared with 0.74 points in the control group. Pain during defecation also improved more in the intervention group.

The anxiety component improved significantly, while depression and overall quality-of-life scores did not show statistically significant between-group improvements.

Participants' overall perception of health improvement was also more favorable in the intervention group. Approximately 47% reported improvement compared with 27% in the control group.

These findings suggest that structured lifestyle coaching may provide additional symptom-related benefits for some patients who are already receiving hormonal therapy.

However, the results require careful interpretation.

The trial was open-label, meaning participants knew whether they were receiving additional lifestyle coaching. Dietary and physical activity interventions were delivered together, making it difficult to determine the independent contribution of either component.

Additional professional attention, behavior-change support, expectations, and other factors may also have influenced patient-reported outcomes.

The trial did not establish that the intervention eliminated endometriotic lesions, prevented recurrence, or improved fertility.

Its value lies in providing encouraging evidence for supportive care, not in demonstrating that lifestyle coaching can replace established medical treatment.

For healthcare professionals, the next question is whether similar support can be delivered safely and feasibly, whether the benefits can be reproduced, and which patients are most likely to benefit.

Restrictive Diets Can Create Additional Problems

Gastrointestinal symptoms are common among people with endometriosis.

Bloating, abdominal discomfort, altered bowel habits, and painful defecation may occur as part of the condition or reflect coexisting disorders such as irritable bowel syndrome.

These symptoms can understandably encourage people to experiment with dietary changes.

Some individuals may benefit from targeted nutritional intervention for a clearly identified gastrointestinal problem.

For example, a time-limited diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols, commonly known as a low-FODMAP diet, may be considered for selected patients with symptoms consistent with irritable bowel syndrome after appropriate evaluation.

However, this is not an established treatment for endometriotic lesions.

Such an approach also requires appropriate reintroduction and individualization rather than indefinite restriction of multiple food groups.

Similarly, gluten-free or dairy-free diets may be necessary for people with specific diagnosed conditions, but those indications should not automatically be extended to everyone with endometriosis.

Repeated food elimination can reduce dietary diversity, compromise nutritional adequacy, increase food-related anxiety, and make everyday life more difficult.

A patient who continues to experience pain despite multiple dietary restrictions should not automatically be encouraged to eliminate additional foods.

Healthcare professionals should instead review whether the changes have produced meaningful benefits, whether nutrition remains adequate, and whether another clinical condition requires attention.

The objective is to support symptom management without turning food into another source of distress.

Supplements Should Not Be Presented as Proven Treatments

Commercial supplements promoted for endometriosis often contain vitamins, antioxidants, curcumin, omega-3 fatty acids, or other ingredients described as reducing inflammation or balancing hormones.

The available evidence remains uncertain.

A systematic review and meta-analysis published online in April 2025 and subsequently included in the 2026 volume of Gynecologic and Obstetric Investigation examined nine randomized placebo-controlled trials involving 545 participants.

The pooled analysis did not demonstrate statistically significant overall benefits of supplements for pelvic pain, menstrual pain, or pain during intercourse.

The authors also identified substantial heterogeneity and methodological concerns, with only a minority of included trials meeting their strictest trustworthiness criteria.

A broader systematic review published online in Reproduction & Fertility on October 20, 2026, examined 24 clinical trials involving 2,019 women with endometriosis.

Some trials reported improvements in selected symptoms or quality-of-life measures, particularly with certain formulations or when supplements were added to conventional therapy.

However, results varied considerably between products and studies. Improvements in some fertility-related measurements did not translate into demonstrated increases in pregnancy rates, and the review did not establish reliable prevention of recurrence after surgery.

These findings should not be interpreted as proving that every supplement is ineffective. They indicate that available evidence is insufficient to recommend supplements routinely as established treatment for endometriosis.

A person with a documented nutritional deficiency may still require appropriate supplementation for that deficiency.

This is different from using high-dose supplements to treat endometriosis without convincing evidence.

Potential adverse effects, interactions with medication, product quality, and treatment costs also deserve attention.

For VLMA, scientific independence requires avoiding commercial endorsements and distinguishing general nutritional care from unproven disease-specific claims.

Physical Activity Can Support Health Without Being a Proven Treatment for Endometriosis Pain

Regular physical activity has established benefits for cardiovascular health, metabolic health, muscle function, and psychological well-being.

People living with endometriosis should not automatically be advised to avoid exercise.

However, persistent pelvic pain, fatigue, painful movement, and pelvic floor symptoms may make certain activities difficult to tolerate.

A person who experiences increased pain during high-impact exercise may need a different approach from someone who finds walking, swimming, or suitable strengthening exercises comfortable.

A systematic review and meta-analysis published in BMC Psychology on October 1, 2026, examined randomized evidence concerning structured exercise interventions for people with endometriosis.

The review included six independent trials, with five contributing to quantitative analyses.

Although several effect estimates favored exercise, the authors concluded that current randomized evidence did not establish a clinically important benefit for endometriosis-related pain or the broader symptom burden.

The certainty of evidence was rated very low for the main outcomes.

This conclusion does not mean that physical activity should be discouraged. Rather, it means that the well-established general health benefits of exercise should be distinguished from uncertain disease-specific effects on endometriosis symptoms.

For some people, gradual aerobic activity may be suitable. Others may benefit from individualized strengthening or rehabilitation after assessment of physical limitations and pain-related concerns.

When pelvic floor muscle dysfunction contributes to symptoms, evaluation by an appropriately qualified pelvic health rehabilitation professional may be useful.

However, pelvic floor physiotherapy should not be presented as a treatment that removes endometriotic lesions.

Exercise should support health and daily functioning rather than become a measure of motivation or a reason to dismiss persistent pain.

Persistent Pain May Involve More Than Visible Lesions

Some people continue to experience pelvic pain after hormonal treatment or surgery.

Persistent symptoms do not necessarily mean that treatment was inappropriate, but they require reassessment.

Residual or recurrent endometriosis may be present. However, pelvic floor dysfunction, overlapping gastrointestinal or urinary disorders, nerve-related pain, and changes in pain processing may also contribute.

Some individuals develop increased sensitivity to painful stimuli over time, particularly when pain has been persistent or recurrent.

These mechanisms are not fully captured by imaging or the number of lesions identified during surgery.

This does not mean the pain is imaginary or primarily psychological.

It means that persistent pelvic pain can involve interacting biological and neurological mechanisms that may require different forms of assessment and care.

The Vietnamese Ministry of Health's 2026 guideline emphasizes optimizing medical treatment and avoiding unnecessary repeated surgery.

For selected patients, multidisciplinary care may include gynecologic reassessment, pelvic health rehabilitation, evaluation of overlapping conditions, and appropriate psychological or pain-management support.

The evidence supporting individual supportive interventions varies, so they should be selected according to clinical findings and the person's needs.

Repeated surgery should not automatically be the next response to persistent pain.

Equally, ongoing pain should not automatically be attributed to stress, anxiety, or inadequate coping.

Appropriate care may need to address both the underlying gynecologic condition and the additional mechanisms contributing to chronic pain.

Sleep, Emotional Health, and Daily Functioning Deserve Attention

Endometriosis can affect much more than the menstrual cycle.

Persistent or unpredictable pain may interfere with sleep, study, employment, physical activity, relationships, and participation in everyday life.

Some people experience fatigue associated with disrupted sleep or the demands of managing chronic symptoms. Others become anxious about future pain episodes, fertility, or the possibility of further treatment.

These experiences deserve attention during clinical assessment.

Psychological support may be appropriate for individuals experiencing anxiety, depression, pain-related distress, or difficulty managing the effects of chronic illness.

Mindfulness-based approaches, relaxation strategies, and other supportive interventions have shown possible benefits in some small studies, but current evidence does not establish one particular technique as a reliably effective treatment for endometriosis.

Psychological care should therefore complement appropriate gynecologic assessment rather than replace it.

Someone should not be told that their pain persists because they are too stressed or have not learned to relax.

Support for sexual well-being may also be important. Pain during intercourse can affect intimacy, relationships, and emotional health.

These concerns require sensitive communication and, when appropriate, specialist assessment.

A person-centered approach recognizes that successful care involves more than changes in anatomical findings. It also includes supporting sleep, daily function, emotional well-being, and participation in meaningful activities.

Environmental Exposures Require Careful Interpretation

The Vietnamese Ministry of Health's 2026 guideline discusses research examining associations between endometriosis and environmental exposures, including selected endocrine-disrupting chemicals, tobacco smoke, and air pollution.

Examples include bisphenols, phthalates, certain heavy metals, and other substances that may influence hormonal or inflammatory pathways.

These are legitimate areas of scientific investigation.

However, an association between an exposure and endometriosis does not necessarily establish that the exposure caused the disease.

It also does not demonstrate that avoiding the exposure after diagnosis will reduce lesions, relieve pain, prevent recurrence, or improve fertility.

Similarly, research into nutritional factors or body weight does not establish that everyone with endometriosis should follow a particular diet or weight-management program.

Some findings may be affected by confounding factors, differences in exposure measurement, and limitations in study design.

General measures to avoid tobacco smoke and reduce unnecessary exposure to harmful pollutants remain appropriate for broader health reasons.

They should not be promoted as proven treatments for endometriosis.

Healthcare professionals should also avoid creating unnecessary fear or financial burdens through expensive environmental testing, specialized products, or commercially marketed hormone-detoxification programs without adequate evidence.

The important distinction is between identifying a possible environmental risk factor and demonstrating that a specific intervention improves clinical outcomes.

Adolescents Need Timely and Age-Appropriate Care

Endometriosis can begin during adolescence, and early symptoms may be mistaken for ordinary menstrual discomfort.

A young person who repeatedly misses school, cannot participate in physical education, or experiences severe pain despite appropriate initial treatment deserves further assessment.

The Vietnamese Ministry of Health's 2026 guideline specifically addresses endometriosis in adolescents and young women.

The American College of Obstetricians and Gynecologists' 2026 diagnostic guideline also applies to adolescents, while recognizing limitations in the available evidence for this age group.

Age-appropriate assessment should begin with careful history-taking and clinically appropriate evaluation.

The choice of examination or imaging should reflect clinical circumstances, age, preferences, and applicable consent requirements.

An invasive pelvic examination or transvaginal ultrasound should not be assumed to be necessary or acceptable for every adolescent.

Alternative imaging approaches may be appropriate when clinically indicated.

Communication is particularly important because young patients may find it difficult to describe menstrual, bowel, urinary, or sexual symptoms.

They should have opportunities to ask questions and participate in decisions in a manner appropriate to their age, understanding, and legal circumstances.

When treatment begins, follow-up should assess both symptom response and possible adverse effects.

The objective is not to diagnose endometriosis in every adolescent with painful periods. It is to ensure that persistent or disabling symptoms are not dismissed without adequate evaluation.

Improving Endometriosis Care in Viet Nam

Viet Nam's Ministry of Health Decision No. 422/QĐ-BYT provides a national professional foundation for improving endometriosis diagnosis and management.

The guideline recognizes different clinical presentations, appropriate imaging, individualized medical treatment, reproductive considerations, and the role of surgery in selected circumstances.

However, the availability of a guideline does not automatically ensure that patients receive timely assessment or coordinated care.

Someone with persistent pelvic pain may first attend a general outpatient clinic, an adolescent health service, or another specialty before reaching a gynecologist.

Another person may primarily report bowel or urinary symptoms without recognizing their relationship to menstruation.

Healthcare professionals who identify suggestive symptom patterns can help patients reach appropriate assessment earlier.

For suspected deep endometriosis involving the bowel, bladder, or ureters, specialist imaging and multidisciplinary evaluation may be necessary.

Patients experiencing infertility may require timely reproductive assessment.

Those with persistent pain despite treatment may need a review of disease activity, overlapping disorders, pelvic floor function, and other pain mechanisms.

These are different clinical pathways.

Not every healthcare facility needs to provide every advanced investigation or intervention, but patients should have access to appropriate referral and follow-up arrangements.

In Viet Nam, geographical access, treatment costs, specialist availability, health literacy, and family or employment responsibilities may influence whether care is timely and sustainable.

However, available evidence does not justify assigning a single nationwide diagnostic delay or level of service quality to all Vietnamese patients without reliable local data.

A more useful approach is for healthcare organizations to examine their own care pathways, identify where delays occur, and consider practical changes that improve access and continuity.

This is a relevant opportunity for professional education and quality improvement.

Lifestyle Support Should Respond to Identified Needs

Lifestyle-related support can contribute to endometriosis care when it addresses a specific clinical or functional need.

A person receiving appropriate medical treatment may continue to experience fatigue, disrupted sleep, or difficulty maintaining physical activity.

Another may have relatively good pain control but experience anxiety about fertility or the effects of long-term treatment.

These situations require different responses.

Nutritional support may be appropriate when there are dietary deficiencies, gastrointestinal symptoms, or other health concerns.

A modified physical activity program may help someone maintain fitness and function without unnecessarily aggravating symptoms.

Psychological support may help selected patients manage emotional distress and the broader consequences of persistent pain.

However, these interventions should not be added automatically as though everyone with endometriosis needs an identical lifestyle program.

Someone with symptoms suggesting bowel involvement should not simply receive an elimination diet without appropriate investigation.

A person experiencing substantial pain during movement may need clinical reassessment or rehabilitation rather than repeated encouragement to exercise more.

Someone concerned about infertility should receive appropriate reproductive counseling instead of being advised to continue trying supplements for several additional months.

The value of Lifestyle Medicine lies in supporting health and daily functioning while ensuring that disease-specific clinical needs are addressed.

The plan should also reflect the person's resources and preferences.

Recommendations requiring expensive imported foods, frequent private therapy sessions, or substantial time away from work may be difficult to maintain.

Shared decision-making should therefore consider scientific evidence, safety, expected benefits, costs, and what matters most to the person receiving care.

Measuring Better Care Requires More Than a Lower Pain Score

Pain intensity is an important outcome in endometriosis, but it does not fully capture the condition's effects.

Two people with similar pain scores may experience very different limitations in work, school attendance, sleep, relationships, and daily activities.

One may prioritize reducing menstrual pain, while another is more concerned about fertility, medication tolerance, or avoiding repeated surgery.

Clinical evaluation should therefore consider outcomes that reflect the person's treatment goals.

These may include menstrual and non-menstrual pelvic pain, painful intercourse, bowel-related pain, physical functioning, quality of life, and the need for further treatment.

Fertility outcomes should be assessed separately when relevant.

A treatment that improves pelvic pain has not necessarily been shown to increase pregnancy or live-birth rates.

Validated patient-reported outcome measures can help support consistent assessment, but their results should be interpreted alongside the clinical question.

The 2026 randomized trial of dietary and physical activity coaching illustrates why this matters. Selected pain outcomes improved, but not every measured quality-of-life or psychological outcome showed a statistically significant benefit.

Healthcare organizations can also evaluate the reliability of clinical pathways.

Useful questions include whether disabling menstrual pain is recognized, whether appropriate imaging or referral occurs, whether treatment response is reviewed, and whether people with suspected deep endometriosis or fertility concerns reach suitable specialist services.

The interval between initial presentation and appropriate assessment may be a useful quality measure when reliable records and consistent definitions are available.

The objective should not simply be to increase the number of consultations, investigations, or lifestyle counseling sessions.

It should be to reduce avoidable delays, support informed decisions, and improve outcomes that are meaningful to patients.

Professional and Legal Responsibilities in Viet Nam

Lifestyle Medicine can contribute to endometriosis care through evidence-based education, appropriate nutritional support, physical activity, health behavior counseling, and attention to psychological and social factors.

However, diagnosing endometriosis, interpreting pelvic imaging, prescribing hormonal treatment, assessing infertility, planning surgery, and managing acute gynecologic conditions are regulated clinical activities.

In Viet Nam, these responsibilities are governed by the Law on Medical Examination and Treatment No. 15/2023/QH15, as amended, and its applicable implementing regulations.

Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, provides an updated consolidated reference to the law.

Healthcare professionals must act within their qualifications, competence, and legally authorized scopes of practice.

Lifestyle Medicine education, international certification, or professional membership does not independently authorize an individual to diagnose endometriosis, prescribe hormonal medication, determine surgical treatment, or provide specialized pelvic rehabilitation outside their permitted professional responsibilities.

The Ministry of Health's Decision No. 422/QĐ-BYT is the relevant national professional guideline on endometriosis diagnosis and treatment as of October 30, 2026.

International guidance from the American College of Obstetricians and Gynecologists, the European Society of Human Reproduction and Embryology, and the National Institute for Health and Care Excellence provides important scientific evidence.

However, these recommendations do not automatically become Vietnamese legal requirements or establish the regulatory approval, availability, or reimbursement status of specific treatments in Viet Nam.

Confidentiality is another important responsibility.

Information concerning menstrual symptoms, sexual health, fertility, pregnancy history, imaging findings, and clinical treatment may constitute sensitive personal data.

The Law on Personal Data Protection No. 91/2025/QH15 and Government Decree No. 356/2025/NĐ-CP, both effective January 1, 2026, establish relevant requirements concerning personal data processing and protection.

Healthcare organizations and educational activities involving identifiable clinical information must consider applicable legal bases, confidentiality obligations, security safeguards, retention requirements, and necessary permissions.

For VLMA, professional educational content should remain distinct from individualized clinical diagnosis, treatment recommendations, or the operation of regulated healthcare services.

Implications for the Vietnam Lifestyle Medicine Alliance

Endometriosis demonstrates why evidence-based Lifestyle Medicine needs to remain connected to established medical care.

Nutrition, physical activity, sleep support, and psychological care may contribute to general health and help selected patients manage aspects of chronic symptoms.

However, evidence for many disease-specific lifestyle interventions remains limited, and these approaches cannot replace appropriate gynecologic assessment or treatment.

For VLMA, an important contribution is to support healthcare professionals in understanding these distinctions through evidence-based education, scientific knowledge exchange, and responsible collaboration.

Educational resources could examine the recognition of persistent pelvic pain, the limitations of diagnostic imaging, current evidence concerning nutrition and exercise, and the importance of protecting reproductive choices.

Professional discussions could also consider how healthcare organizations reduce diagnostic delays, coordinate specialist referrals, and evaluate outcomes that matter to people living with endometriosis.

Such work would benefit from collaboration with appropriately qualified specialists in gynecology, reproductive medicine, pain management, rehabilitation, clinical nutrition, and related fields.

VLMA is a physician-led professional platform operated by Vietnam Lifestyle Medicine Alliance Company Limited. Its activities focus on evidence-based professional education, capability development, scientific knowledge exchange, and collaboration.

VLMA does not independently diagnose endometriosis, prescribe hormonal medication, interpret pelvic imaging for individual clinical decisions, provide fertility treatment, or deliver specialized pelvic rehabilitation.

Its contribution lies in strengthening professional understanding and supporting the responsible interpretation of scientific evidence within authorized healthcare services.

Timely Diagnosis and Appropriate Support Belong Together

Endometriosis illustrates why evidence-based Lifestyle Medicine requires both scientific caution and attention to the person's lived experience.

Some people may benefit from dietary adjustments, suitable physical activity, sleep support, or psychological and rehabilitative interventions. Recent research suggests that structured lifestyle coaching may provide additional symptom-related benefits when combined with established treatment.

However, no single lifestyle program has been shown to reliably treat endometriosis itself, eliminate lesions, prevent recurrence, or improve fertility outcomes across patient populations.

At the same time, care should not focus exclusively on visible lesions while overlooking persistent pain, fatigue, emotional well-being, and the person's ability to participate in everyday life.

The updated Vietnamese guideline and international recommendations available in 2026 reinforce the importance of early recognition, individualized treatment, and shared decision-making.

For healthcare professionals in Viet Nam, the opportunity is to connect these principles through timely assessment, appropriate referral, evidence-based medical care, and supportive interventions that respond to actual patient needs.

A person experiencing disabling menstrual pain should not have to spend years trying different diets or supplements before receiving a meaningful clinical assessment.

Nor should improvements in general health be mistaken for evidence that the underlying disease has resolved.

The contribution of Lifestyle Medicine is to support health and daily functioning while ensuring that people with endometriosis receive timely diagnosis, appropriate treatment, and care that respects their pain, reproductive goals, and quality of life.

Selected References

1. Ministry of Health of Viet Nam. Decision No. 422/QĐ-BYT Issuing the Guidelines for Diagnosis and Treatment of Endometriosis. February 11, 2026. Replacing Decision No. 5306/QĐ-BYT dated November 7, 2019.

2. American College of Obstetricians and Gynecologists. Diagnosis of Endometriosis: ACOG Clinical Practice Guideline No. 11. Obstetrics & Gynecology. 2026;147(3):432–448. DOI: 10.1097/AOG.0000000000006181.

3. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE Guideline: Endometriosis. Human Reproduction Open. 2022;2022(2). DOI: 10.1093/hropen/hoac009.

4. National Institute for Health and Care Excellence. Endometriosis: Diagnosis and Management. NICE Guideline NG73. Diagnostic recommendations updated November 11, 2024.

5. World Health Organization. Endometriosis. Fact sheet. Updated October 15, 2025.

6. Donati A, Giola F, Privitera G, et al. Diet and Physical Activity Coaching for Well-being and Pain Reduction in Patients With Symptomatic Endometriosis: A Randomized-Controlled Clinical Trial. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2026;326:115381. Published online August 17, 2026. DOI: 10.1016/j.ejogrb.2026.115381.

7. Sun M, Zhu Y, Wang L, et al. Effects of Structured Exercise Training on Pain and Multidimensional Symptom Burden in Women With Endometriosis: An Updated Systematic Review and Meta-analysis. BMC Psychology. Published October 1, 2026. DOI: 10.1186/s40359-026-05724-7.

8. Hough B, Drever N, Manger S. What Is the Evidence on Lifestyle Interventions for the Symptom Management of Pelvic Pain in Women With Endometriosis or Adenomyosis? A Scoping Review. American Journal of Lifestyle Medicine. Published online February 24, 2026. DOI: 10.1177/15598276261419770.

9. Fuentes Rodríguez A, Grela Beres Ó. Influence of Diet and Physical Exercise on Endometriosis: A Systematic Review. Revista Cuidarte. 2026;17(1). DOI: 10.15649/cuidarte.5426.

10. Salmeri N, Ragusi A, Buffo C, Somigliana E, Viganò P, Vercellini P. Dietary Supplements for Endometriosis-Associated Pain: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. Gynecologic and Obstetric Investigation. 2026;91(1):101–114. Published online April 26, 2025. DOI: 10.1159/000545414.

11. Seven M, Galla L, Gstoettner M, Wenzl R. Nutritional Supplements in the Treatment of Endometriosis-Associated Symptoms: A Systematic Review. Reproduction & Fertility. Published online October 20, 2026. DOI: 10.1530/RAF-26-0079.

12. Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. First published online October 28, 2025. DOI: 10.1177/15598276251379821.

13. Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH: Law on Medical Examination and Treatment. February 26, 2026.

14. National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. June 26, 2025. Effective January 1, 2026.

15. Government of Viet Nam. Decree No. 356/2025/NĐ-CP Detailing Selected Provisions and Implementation Measures of the Law on Personal Data Protection. December 31, 2025. Effective January 1, 2026.

Editorial and Professional Scope Note

This article presents an educational and professional perspective of the Vietnam Lifestyle Medicine Alliance on the contribution and limitations of evidence-based Lifestyle Medicine in endometriosis care, based on information reviewed through October 30, 2026.

It is intended for professional information, education, and scientific knowledge exchange. It does not constitute a clinical practice guideline, individualized medical advice, a diagnostic or treatment protocol, dietary prescription, exercise prescription, reproductive treatment recommendation, or authoritative interpretation of Vietnamese law.

Vietnam Lifestyle Medicine Alliance (VLMA) is a physician-led professional platform operated by Vietnam Lifestyle Medicine Alliance Company Limited. VLMA is not a licensed medical examination or treatment facility, gynecologic care provider, fertility treatment provider, medical licensing authority, or healthcare accreditation organization. It does not independently diagnose endometriosis, prescribe hormonal medication, interpret clinical investigations for individual treatment decisions, perform gynecologic procedures, provide fertility treatment, or deliver specialized pelvic rehabilitation.

Clinical assessment, diagnosis, prescribing, gynecologic treatment, surgical decisions, fertility assessment, rehabilitation, and follow-up must be undertaken by appropriately qualified and authorized healthcare professionals and facilities within their applicable scopes of practice and in accordance with relevant Vietnamese requirements.

Lifestyle-related interventions should not delay or replace necessary gynecologic assessment, medical treatment, specialist evaluation, reproductive care, or emergency services. Persistent or worsening pelvic pain requires appropriate reassessment, while sudden severe pelvic pain, significant bleeding, fainting, fever, or other concerning symptoms may require urgent medical evaluation.

Evidence concerning specific dietary patterns, supplements, structured exercise programs, and other supportive interventions remains limited or uncertain. Findings from individual studies should not be interpreted as proof that lifestyle interventions eliminate endometriotic lesions, prevent recurrence, or improve pregnancy or live-birth outcomes.

International clinical guidelines and research findings are cited for educational purposes. Their inclusion does not imply that they automatically have regulatory force in Viet Nam or that VLMA has formally adopted, delivered, validated, endorsed, or certified any endometriosis management or treatment program discussed in this article.

The illustrative patient situations are hypothetical and do not describe actual VLMA clinical activities or identifiable patients.